載入中
Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma. A prime example of their work is the development of an investigational portable neuromodulation stimulator. This device uniquely delivers neurostimulation through the tongue. Clinical studies have indicated that this approach significantly enhances the efficacy of physical exercises for individuals experiencing neurological symptoms stemming from conditions like disease or trauma, including mild-to-moderate traumatic brain injury. Established on March 13, 2014, Solana Co. maintains its headquarters in Newtown, Pennsylvania.
一般交易時段
US$2.435
+US$0.045 · +1.88%
盤中時間採用ET。市場資料可能有所延遲。
Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma. A prime example of their work is the development of an investigational portable neuromodulation stimulator. This device uniquely delivers neurostimulation through the tongue. Clinical studies have indicated that this approach significantly enhances the efficacy of physical exercises for individuals experiencing neurological symptoms stemming from conditions like disease or trauma, including mild-to-moderate traumatic brain injury. Established on March 13, 2014, Solana Co. maintains its headquarters in Newtown, Pennsylvania.
日內區間
目前US$2.435
52週區間
目前US$2.435
盤中時間採用ET。市場資料可能有所延遲。
Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma. A prime example of their work is the development of an investigational portable neuromodulation stimulator. This device uniquely delivers neurostimulation through the tongue. Clinical studies have indicated that this approach significantly enhances the efficacy of physical exercises for individuals experiencing neurological symptoms stemming from conditions like disease or trauma, including mild-to-moderate traumatic brain injury. Established on March 13, 2014, Solana Co. maintains its headquarters in Newtown, Pennsylvania.
日內區間
目前US$2.435
52週區間
目前US$2.435
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 601.7萬 USD | 52萬 USD | 64.4萬 USD | 78.7萬 USD | 52.2萬 USD |
| 銷貨成本 | 50萬 USD | 58.2萬 USD | 58.3萬 USD | 46.3萬 USD | 29.8萬 USD |
| 毛利 | 551.7萬 USD | −6.2萬 USD | 6.1萬 USD | 32.4萬 USD | 22.4萬 USD |
| 研究與開發 | 351.1萬 USD | 365.9萬 USD | 294.2萬 USD | 426.2萬 USD | 599萬 USD |
| 銷售、一般及管理費用 | 2312.7萬 USD | 1011.8萬 USD | 927.1萬 USD | 1064萬 USD | 1217.6萬 USD |
| 營業費用 | 2663.8萬 USD | 1384.1萬 USD | 1248.9萬 USD | 1584萬 USD | 1836.6萬 USD |
| 利息收入 | — | — | 25.7萬 USD | — | — |
| 利息支出 | 63.5萬 USD | 1.7萬 USD | — | 83.4萬 USD | — |
| 折舊和攤銷 | 68萬 USD | 6萬 USD | 16.2萬 USD | 25.5萬 USD | 31.2萬 USD |
| 營業利益 | −2112.1萬 USD | −1390.3萬 USD | −1242.8萬 USD | −1551.6萬 USD | −1814.2萬 USD |
| 淨利 | −4089萬 USD | −1174.2萬 USD | −885萬 USD | −1407.2萬 USD | −1813.2萬 USD |
公司資料更新於 2026年10月12日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
| 行動 | 生效日期 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股票分割 | 2025年7月1日 | 1:50 | — | — |
股票分割 | 2025年5月2日 | 1:15 | — | — |
股票分割 | 2023年8月17日 | 1:50 | — | — |
股票分割 | 2021年1月4日 | 1:35 | — | — |
股票分割 | 2018年1月23日 | 1:5 | — | — |
已生效 2025年7月1日
1:50
已生效 2025年5月2日
1:15
已生效 2023年8月17日
1:50
已生效 2021年1月4日
1:35
已生效 2018年1月23日
1:5
報告持有此股票曝險的交易所交易基金。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
